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Objective: Social withdrawal is described as the condition in which an individual experiences a desire to make
social contact, but is unable to satisfy that desire. It is an important issue for patients withmotor neurone disease
who are likely to experience severe physical impairment. This study aims to reassess the psychometric and
scaling properties of the MND Social Withdrawal Scale (MND-SWS) domains and examine the feasibility of a
summary scale, by applying scale data to the Rasch model.
Methods: TheMNDSocialWithdrawal Scalewas administered to 298 patientswith a diagnosis ofMND, alongside
theHospital Anxiety andDepression Scale. The factor structure of theMNDSocialWithdrawal Scalewas assessed
using conﬁrmatory factor analysis. Model ﬁt, category threshold analysis, differential item functioning (DIF),
dimensionality and local dependency were evaluated.
Results: Factor analysis conﬁrmed the suitability of the four-factor solution suggested by the original authors.
Mokken scale analysis suggested the removal of item ﬁve. Rasch analysis removed a further three items; from
the Community (one item) and Emotional (two items) withdrawal subscales. Following item reduction, each
scale exhibited excellent ﬁt to the Rasch model.
A 14-item Summary scale was shown to ﬁt the Rasch model after subtesting the items into three subtests
corresponding to the Community, Family and Emotional subscales, indicating that items from these three
subscales could be summed together to create a total measure for social withdrawal.
Conclusion: Removal of four items from the Social Withdrawal Scale led to a four factor solution with a 14-item
hierarchical Summary scale that were all unidimensional, free for DIF and well ﬁtted to the Rasch model. The
scale is reliable and allows clinicians and researchers to measure social withdrawal in MND along a unidimen-
sional construct.© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Motor neurone disease (MND) is a progressive neurodegenerative
disease of unknown aetiology that is characterised by weakness in
limb and bulbar muscles, culminating in respiratory failure and death.
No curative treatments exist for the disease. Progression is often rapidC, Centre for Primary Care, The
Road, M13 9PL, UK. Tel.: +44
Gibbons).
. Open access under CC BY-NC-ND liceand may present a serious challenge for patients with MND who need
to cope not only with a terminal diagnosis but also with the intense
demands of a potentially steep decline in physical function.
There is a growing body of literature which demonstrates, perhaps
paradoxically, that quality of life in MND is only weakly related to
impairments in physical function that deﬁne the disease [1–4]. The
psychological consequences of the illness and their relationship to
patient quality of life have been increasingly examined over recent
years and ﬁndings have shown strong relationships between social
support, depression, coping, fatigue and patient quality of life [4–8].
Social withdrawal has not only been described as the condition in
which an individual experiences a desire to make social contact, but is
unable to satisfy that desire [9], butmay also be described as a conscious
desire for reduced social interaction due to increased anxiety ornse.
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for patients with other neurological illnesses, such as Parkinson's
disease (PD) [12] and multiple sclerosis (MS) [13].
People with MND often experience social withdrawal from
family, friends and events occurring outside the home. Patients
commonly report that they are less socially attached following
diagnosis, including fewer visits from friends and church atten-
dances and may describe visits to their doctor or MND clinic as
their most common form of social interaction [11]. Low levels of
social interaction are related to increased levels of psychological
distress in MND patients. Conversely, high levels of social support
are related to increased quality of life in MND [2]. Recent calls have
been made to develop psychological therapies speciﬁcally for MND
patients and their carers [14,15] and, given its relationship with
quality of life and depression, social withdrawal may make a point
of departure for future interventions.
A disease-speciﬁc measure has been designed to assess social with-
drawal from the perspective of the MND patient across four domains
measuringwithdrawal across domains of Community, Family, Emotional
and Physical Withdrawal [16]. The original scale consists of 24 items
scored along a four point Likert-type response ranging from Strongly
Disagree (scored 0) to Strongly Agree (scored 3). Items were derived
from semi-structured interviews carried out with MND patients. Consis-
tent with the patient-led rationale of the original study, domains were
conceptually based on the manner in which interviewed MND patients
described their experiences of social withdrawal.
The original study found SW, particularly from the community, to
be strongly associated with depression and physical symptoms of the
disease [16]. Further research using this measure has found SW from
family and friends to be associated with reduced quality of life [17].
Other researchers using the MND-SWS Scale have found higher
levels of social withdrawal in patients who were struggling to cope
with the disease. Those patients found to have difﬁculty in coping
also scored highly for depression and anxiety [18].
The SWS was developed on a relatively small sample of MND
patients (N = 23), meaning reduced power in statistical tests [19];
with a potential error rate of up to 30% [20]. In addition to the inherent
risks of developing scales on small samples, measures developed using
classic test theory (CTT) will always be ordinal, which may affect the
accuracy of arithmetic operations and comparison of raw scores [21].
A further caveat of the four disparate factors of the original scale was
that no analysis was conducted to conﬁrm that they could also form a
single unidimensional construct, allowing estimation of a total score
for social withdrawal.
The Rasch model [22] is a modern psychometric approach that
permits interval-level measurement from pencil-and-paper question-
naires. Rasch techniques have been shown to successfully reduce the
number of items on questionnaires [23], a particularly important issue
when developing questionnaires for disabled populations [24].
The impetus of the current study is to assess the psychometric and
scaling properties of the MND-SWS from a Rasch measurement
perspective and, in doing so, to evaluate the psychometric properties of
the four subscales of the MND-SWS, and to provide a unidimensional
Summary scale of social withdrawal.
2. Methods
2.1. Main data collection
The psychometric and scaling properties of the MND-SWS were
assessed among 298 patients recruited from ﬁve regional MND care
centres: the Walton Centre for Neurology and Neurosurgery in
Liverpool, Preston Royal Hospital, Oxford John Radcliffe Hospital,
Salford Hope Hospital, and Shefﬁeld Royal Hallamshire Hospital. All
participants had a diagnosis of MND from a neurologist with exper-
tise in MND. Patients were unselected for age, sex, and symptompresentation or disability status. The MND-SWS was administered
as part of a questionnaire suite that contained a number of psycho-
metric instruments, including the Hospital Anxiety and Depression
Scale [25] modiﬁed for use with MND patients [26] and the Neuro-
logical Fatigue Index-MND [27]. Contemporaneous functional status
information was taken for 142 patients using the ALS Functional
Rating Scale — Revised (ALSFRS-R) [28] in clinic within a month of
either side of questionnaire completion. Questionnaires were either
handed out during a routine clinic appointment or sent to the
patients' homes over a period of twelve months. Where patients
were unable to complete the pack by themselves a nurse or caregiver
was allowed to act as a scribe. Each participant gave informed
consent.
Ethical permission was granted for this study from relevant hospital
committees in the U.K. (Sefton 05/Q0401/7 and Tayside 07/S1402/64),
and local research governance committees at all participating sites.
2.2. Statistical analysis
An initial exploration of the factor structure of the existing scale
was undertaken with a conﬁrmatory factor analysis (CFA) based
upon the four domain structure. The purpose here is to provide
conﬁrmation of the structure so as to include the extant domains
within the Rasch analysis. Consequently a ‘weak’ conﬁrmation is
used with an associated ﬁt statistic (RMSEA of b0.10) as indicative
of a minimum conﬁrmed structure. The CFA factors will be rotated
using oblique Geomin rotation with weighted least squares mean-
and variance-adjusted estimation. Should the CFA fail, an exploratory
factor analysis (EFA) would be undertaken. More rigorous post-hoc
tests of unidimensionality will be undertaken within the Rasch analysis
(detailed below). Prior to this, a non-parametric probabilistic (Mokken)
model will be used to screen the domain items for a probabilistic
structure that would be consistent with the Rasch model [29]. A
Loevinger's coefﬁcient value of b0.3 would indicate an item not consis-
tent with this structure [30].
To evaluate the scaling properties and construct validity of theMND-
SWS, the Rasch measurement model was used [22]. Rasch analysis
ensures that the fundamental scaling properties of an instrument are
assessed alongside traditional psychometric assessments of reliability.
The model operationalises the formal axioms of measurement (order,
unidimensionality and additivity) [31]. Unlike classical approaches, it
allows the creation of interval level measurement from questionnaire
measures given certain criteria [32]. A sample size of 243 will provide
accurate estimates of item and person locations irrespective of scale
targeting [33].
Analyses used to assess whether the scale conforms to Rasch model
expectations are brieﬂy explained below. A comprehensive reviewwith
a more detailed explanation of the Rasch analytical process may be
found elsewhere [34]. The unconditional ‘partial credit’ polytomous
Raschmodel was usedwith conditional pair-wise parameter estimation
[35].
Rasch model ﬁt is primarily indicated by a non-signiﬁcant deviation
frommodel expectations across a range of ﬁt statistics. For example, the
summary chi-square statistic should be non-signiﬁcant, after adjusting
for multiple testing. In addition, both person ﬁt and item ﬁt are assessed
by their residual mean values. This examines the differences between
the observed data and model expectations for each person and each
item estimate. At the summary level, perfect ﬁt is represented by a
mean of zero and a standard deviation (SD) of ±1, whilst at the
individual level for persons and items, a residual value of ±2.5 is
appropriate.
Reliability for Rasch scales is described as the extent to which items
distinguish between distinct levels of functioning and is shown statisti-
cally using the Person Separation Index (PSI) (where 0.7 is considered a
minimal value for research use; 0.85 for clinical use) [36]. Where the
distribution is normal the PSI is equivalent to Cronbach's alpha.
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of two independent estimates, which are subjected to a t-test. These
estimates are derived from the loadings on the ﬁrst principal compo-
nent analysis of the residuals, and the latent estimate of each person
(and its standard error) calculated independently for each test.
These estimates are then compared and the number of signiﬁcant
t-tests outside the ±1.96 range indicates whether the scale is unidi-
mensional or not. Generally, where less than 5% of the t-tests are
signiﬁcant this is indicative of a unidimensional scale (or the lower
bound of the 95% binomial conﬁdence interval is below 5%) [37].
Rasch analysis permits the evaluation of important psychometric
criteria, including local dependency, category threshold disordering
and differential item functioning (DIF). Local dependency occurs
when two questions on a scale are too similar, leading to artiﬁcially
inﬂated reliability. Item category threshold disordering occurs
where patients cannot reliably distinguish between response
categories (i.e. points on a Likert scale). Differential item functioning
occurs when different demographic groups within the sample
respond in a different way to a certain question. In the present
study DIF was assessed by age, sex and functional ability. Further
details of Rasch analysis are comprehensively provided elsewhere
[26,34].
For the analysis of DIF by functional impairment, scores on the
ALSFRS-R were categorised into three groups representing patients in
the lower, middle and upper tertiles within the sample. These groups
represented ALSFRS-R scores of 29 or less (n = 48), 30 to 38 (n = 58)
and 39 to 45 (n = 36).
When necessary, items are removed one at a time. Once an item is
removed the resultant scale is reassessed for ﬁt, dimensionality, local
dependency and DIF. This iterative process is repeated until an
acceptable solution is found. This process has been used in previous
Rasch studies [26,38].
The CFA was undertaken with MPlus [39], Rasch analysis with
RUMM2030 [40], and the Mokken scaling with STATA [41].
3. Results
3.1. Patient sample
Summary demographic information and questionnaire response by
centre are displayed in Table 1.
3.2. Conﬁrmatory factor analysis
Conﬁrmatory factor analysis (CFA) conﬁrmed the suitability of the
four-factor structure suggested by the original authors. The original
solution displayed acceptable initial dimensionality (RMSEA = 0.09)Table 1
Demographics and questionnaire response by centre.
Demographics N = 298 n(%), M ± SD
(range)
Age 62.09 ± 11.01
Sex 62.4% male
Questionnaires completed
at home
278 (93.3%)
Disease duration (years) 2.69 ± 3.54
ALSFRS-R score 32.6 (12–48)
Patients recruited from each
research centre
Liverpool 110 (36.9%)
Shefﬁeld 38 (12.8%)
Oxford 39 (13.1%)
Salford 76 (25.5%)
Preston 35 (11.7%)[42] before more rigorous tests of dimensionality are conducted within
Rasch analysis [37]. Mokken scale analysis of the four-factor structure
suggested the removal of item 5 ‘No longer use telephone’ from the
‘Community Withdrawal’ factor.
3.3. Rasch analysis
Each subscale was tested separately using the Raschmodel to assess
unidimensionality and ﬁt to the Rasch model. All items apart from item
5 from the original scale were taken into Rasch analysis.
3.4. Community Withdrawal subscale
The 5-item CommunityWithdrawal subscale displayed initial misﬁt
to the Raschmodel (see Table 2, Community Initial). Analysis of item ﬁt
residuals revealed that item 4 ‘Still participate in everything’ was
misﬁtting the Rasch model (χ2 = 19.39 [4], p b 0.01). Scale ﬁt was
improved following the removal of item 4; including acceptable
targeting, dimensionality and reliability (see Table 2, Community
Final). The modiﬁed Community Withdrawal subscale has ordered
category thresholds, has no local dependency and is free from DIF by
age, gender or functional impairment.
3.5. Family Withdrawal subscale
The 6-itemFamilyWithdrawal subscale displayed excellent summary
ﬁt to the Raschmodel and did not require anymodiﬁcation. Item9 ‘Enjoy
the company of friends’ did displaymisﬁt to the Raschmodel (χ2 = 13.7
[4], p = 0.01) but overall scale ﬁt was not improved by removal of this
item so it was retained. Item category thresholds were correctly ordered.
Summary ﬁt statistics are given for the ﬁnal subscale in Table 2. Items
were locally independent and no DIF by age, gender or functional
impairment.
3.6. Emotional Withdrawal
The Emotional Withdrawal subscale did not display good ﬁt to the
Rasch model (see Table 2, Emotional Initial). Item 14 ‘Want to go and
do things’ displayed high residual ﬁt and poor ﬁt to the Rasch model
(Fit residual = 6.56; χ2 = 93.2 [4], p b 0.001) and was removed from
the scale. Thresholds were correctly ordered and did not require any
restructuring. Reanalysis of the revised Emotional Withdrawal subscale
revealed that item 17 ‘Embarrassed in public places’ also displayed
misﬁt to the Rasch model (χ2 = 13.32 [4] p b 0.05). Upon the removal
of items 14 and 17, the Emotional Withdrawal scale displayed excellent
ﬁt to the Rasch model, including unidimensionality, ordered category
thresholds, absence of DIF by age, gender or functional impairment, no
local dependency, good reliability and acceptable scale targeting.
3.7. Physical Withdrawal
The original Physical Withdrawal subscale displayed adequate ﬁt to
the Rasch model (p = 0.04). Whilst item 19 ‘Physical condition
prevents me from doing what I want to do’ displayed a high positive
ﬁt residual, removal of the item did not improve ﬁt to the scale; and
so it was retained. The scale demonstrated good dimensionality, local
independence of items and ordered category thresholds (see Table 2,
Physical: Final). A large ceiling effect was apparent, with 17.91% of
respondents scoring the maximum score for the subscale.
The PhysicalWithdrawal subscale did not display DIF by age, gender
or level of functional impairment.
The high ceiling effect present for this subscale is shown in Fig. 1.
Bars above the x-axis of the scale represent the person location in logits
and bars below the x-axis represent item threshold location in logits. In
spite of this ceiling effect, there is a good spread of item difﬁculty
(clusters below the x-axis), ranging from−2.5 to 2.2 logits.
Table 2
Summary ﬁt statistics for the Social Withdrawal Scale.
Analysis name # of items Item residual Person residual Chi square PSI Unidimensional test (CI %) Extreme scores (%)
Mean ±SD Mean ±SD Value p
Community: Initial 5 0.88 2.45 −0.36 1.26 106.51 b0.001 0.78 3.61% (1.70–6.50) 7.00%
Community: Final 4 0.72 0.81 −0.44 1.11 22.7 0.12 0.76 0.78% (0.10–2.80) 14.42%
Family: Final 6 0.3 1.18 −0.39 1.22 34.39 0.08 0.67 4.79% (2.60–7.90) 2.01%
Emotional: Initial 6 0.2 3.38 −0.52 1.5 160.53 b0.001 0.78 6.94% (4.30–10.5) 3.36%
Emotional: Final 4 0.14 1.08 −0.91 1.84 17.4 0.36 0.75 3.90% (1.96–6.87) 5.37%
Physical: Final 6 −0.05 1.67 −0.34 1.03 37.9 0.04 0.91 4.15% (2.00–6.90) 19.13%
Summary: Initial 20 0.24 2.12 −0.38 1.67 196.08 b0.001 0.82 17.91% (16.10–26.60) 0.67%
Summary: Final 14a 0.4 1.22 −0.37 1.51 4.52 0.97 0.65 0.72% (0–3.3) 0.68%
Ideal values 0 b1.4 0 b1.4 N0.01 N0.85 b5% (CI b 0.05) b10%
Key: SD— standard deviation, p — probability, PSI — Person Separation Index, CI— conﬁdence interval.
a Items collapsed into 3 subtests representing the Community, Family and Emotional subscales.
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In order to assess the potential suitability of the Social Withdrawal
Scale as a total measure of withdrawal the 20 items from the four
constituent subscales were analysed. Initial analysis of the 20 items
showed misﬁt to the Rasch model that appeared to be driven by
multidimensionality within the dataset (see Table 2, Summary: Initial).
For the purposes of the analysis, the 20 items were arranged into four
subtests, with each subtest consisting of the items from the four
subscales. Arranging the items in this manner would allow Rasch
analysis to evaluate each subscale as a single item when analysing ﬁt for
the Summary scale. Subtesting the items improved ﬁt however uniform
DIF was present for the ‘Physical’ subscale (f(2) = 9.53, p b 0.001).
Resultantly, the Physical subscale was removed from the Summary scale
analysis. Following the removal of these items, the ﬁnal 14-item Summa-
ry scale yielded excellent ﬁt to the Rasch model (see Table 3, Summary
Final); including unidimensionality, reliability and absence of DIF or
local dependency.
Fig. 2 shows the person–item threshold distribution for the Summa-
ry scale. On the Summary scale persons (shown above the x-axis) are
normally distributed and the incidence of patients falling at the ﬂoor
and ceiling is an acceptable 1.68%. Scale information, indicated by
large clusters of items beneath the x-axis, appears to be maximisedFig. 1. Person–item threshold distribution for Physical subscale. This ﬁgure shows the distributi
effect is evident between 2.2 and 3.8 logits.between −2.5 and 2.8 logits, where the majority of patients fall.
Reliability was higher when the Summary scale was analysed without
subtests (PSI = 0.82, Cronbach's alpha = 0.81).
Individual item ﬁt statistics for all subscales are displayed in Table 3.
3.9. Raw score to interval scale conversion
Table 4 provides a simple chart for allowing conversion of raw scores
taken from each of the four subscales into interval level scores for use in
arithmetic operations. These conversions will hold provided there are
no missing data. Parametric statistics can then be utilised, given appro-
priate distributional assumptions.
3.10. Comparison of MND Social Withdrawal Scale with physical function-
ing, fatigue and psychological distress
Table 5 displays Spearman's correlation coefﬁcients between the
MND-SWS subscales and other variables. The 15-item MND-SWS
Summary scale is strongly associated with depression (rs = .61,
p b 0.05), anxiety (rs = .42, p b 0.05) and fatigue (rs = .40, p b 0.05),
but was less strongly related to functional status (rs = − .30,
p b 0.05). The Physical Withdrawal scale was strongly correlated with
functional status (rs = − .61, p b 0.05), but not to such a degree thaton of person and item thresholds (above the x-axis) and item (below the x-axis). A ceiling
Table 3
Item ﬁt statistics for the ﬁnal subscales.
Item Location SE FitResid. ChiSq. Prob.
Community subscale 1 0.44 0.08 1.51 8.23 0.08
2 0.11 0.09 0.80 3.26 0.51
3 0.30 0.08 0.96 2.63 0.62
6 −0.85 0.09 −0.40 8.59 0.07
Family subscale 7 0.34 0.09 0.56 4.34 0.23
8 −0.15 0.08 0.36 2.88 0.41
9 0.93 0.11 −0.16 13.7 0.01
10 0.12 0.08 −1.59 4.32 0.23
11 −0.55 0.07 0.59 2.63 0.45
12 −0.69 0.08 2.03 9.14 0.03
Emotional subscale 13 −0.11 0.09 0.94 4.56 0.35
15 −0.07 0.10 −1.43 10.08 0.04
16 −0.03 0.09 0.31 1.05 0.90
18 0.20 0.10 0.75 1.72 0.78
Physical subscale 19 −1.04 0.12 2.92 13.31 0.01
20 0.52 0.10 −1.39 4.91 0.30
21 −0.20 0.10 0.83 1.24 0.87
22 0.51 0.10 −0.66 4.04 0.40
23 0.23 0.09 −0.58 4.00 .0.41
24 0.86 0.09 −1.45 10.41 0.03
Key— SE = Standard Error; FitResid. = Fit Residual; ChiSq. Chi Square; Prob— Probability.
Table 4
Conversion table for raw to interval score for Social Withdrawal subscales.
Raw score Sum. Com. Emo. Phys. Fam. Raw score
0 0.00 0 0 0 0 31
1 3.82 1.53 1.37 1.51 2.09 32
2 6.38 2.65 2.55 2.87 3.62 33
3 8.08 3.45 3.55 4.12 4.75 34
4 9.40 4.13 4.5 5.27 5.68 35
5 10.48 4.73 5.38 6.31 6.52 36
6 11.42 5.34 6.18 7.26 7.29 37
7 12.26 5.96 6.93 8.12 7.98 38
8 13.03 6.68 7.68 8.91 8.68 39
9 13.76 7.55 8.48 9.63 9.35 40
10 14.44 8.65 9.39 10.29 10.02 41
11 15.09 10.09 10.54 10.94 10.71 42
12 15.72 12 12 11.58 11.43 43
13 16.33 12.23 12.2 44
14 16.92 12.93 13.02 45
15 17.51 13.75 13.93
16 18.08 14.72 14.93
17 18.64 16.08 16.28
18 19.20 18 18
19 19.75
20 20.31
21 20.87
22 21.43
23 21.99
24 22.56
25 23.13
26 23.71
27 24.30
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used in all analyses.28 24.91
29 25.52
30 26.15
Key: Com. = Community subscale; Emo. = Emotional scale; Phys. = Physical subscale;
Sum. = Summary scale.4. Discussion
Living with motor neurone disease is a potentially devastating
experience, which may be worsened if patients become socially with-
drawn. In order to facilitate further social withdrawal research, we
provide a modiﬁed version of the MND-SWS questionnaire that is
capable of interval-level measurement of social withdrawal across
four domains and a Summary scale.
Research that examines the role of social withdrawal in the determi-
nation of psychological distress and quality of life will be well placed to
inform the development of novel psychological therapies in this popula-
tion. In the present study, socialwithdrawalwas shown to be associated
with increased levels of depression and anxiety and reduced functionalFig. 2. Person–item threshold distribution for Summary scale. This ﬁgure displays the person–ite
x-axis that fall within the range of the items (below the x-axis).ability. These results are congruent with previous research [16] and
suggest that further investigation of social withdrawal may provide
important insight into the complex relationship between quality of life
and functional status in MND patients.
Social withdrawal has also been shown to affect quality of life in
other neurological conditions, including Parkinson's disease [12] and
multiple sclerosis [13]. Further work could be undertaken with other
neurological patient groups to adapt the MND-SWS Scale for use in
these conditions, facilitating better understanding of the processesmthreshold distribution for the Summary scale. The normal distribution of bars above the
Table 5
Spearman's correlation coefﬁcients between study variables.
ALSFRS-R HADS-D HADS-A NFI-MND SWS Community SWS Family SWS Physical SWS Emotional SWS Summary
ALSFRS 1
HADS-D 1
HADS-A .54 1
NFI-MND .46 .51 1
SWS Community − .34 .57 .46 1
SWS Family .35 .30 1
SWS Emotional .41 .34 .33 .38 1
SWS Physical − .61 .44 .44 .61 .30 1
SWS Summary − .30 .61 .42 .40 .69 .75 .73 .49 1
Key: ALSFRS = Amyotrophic Lateral Sclerosis Functional Rating Scale — revised; HADS = Hospital Anxiety and Depression Scale — Depression; D = Depression; A = Anxiety; NFI-
MND = Neurological Fatigue Index-Motor Neurone Disease; SWS = Social Withdrawal Scale.
Spearman's rank correlations all signiﬁcant at p b 0.05. Effect sizes below .3 suppressed.
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diseases. Recent calls have been made to develop psychological thera-
pies speciﬁcally for MND patients and their carers [14,15].
The original four-factor structure of the MND-SWS was supported
by factor and Rasch analysis. Only one item “I no longer use the
telephone as much as I used to, prior to MND” was identiﬁed by the
Mokken scale analysis as being unsuitable and was removed prior to
Rasch analysis. A further three items that displayed either poor ﬁt to
the Rasch model or high ﬁt residuals were omitted.
A large ceiling effectwas apparent for the ‘Physical’ subscale, with 74
patients (19%) scoring beyond themaximum range of this subscale. This
suggests that the Physical subscale is primarily useful for measuring
Physical Withdrawal in patients who do not experience severe physical
impairment. In contrast, the Summary scale, which excluded the items
from the Physical Withdrawal subscale, was well targeted, with less
than 1% of extreme scores, indicating that the scale is suitable for use
with all MND patients, regardless of disease duration or functional
impairment.
It should be noted that items 9 and 19 were retained in the ‘Family’
and ‘Physical’ subscales despite displayinghighﬁt residuals. These items
were retained as their removal did not improve Rasch model ﬁt, and
their inclusion will serve to maximise scale information. Further
research should test the suitability of these two items in a separate
population.
The Person Separation Index (PSI) value for the Summary scale is
sufﬁcient for research use but falls below the recommended threshold
for clinical use. Analysis of the person–item threshold distributions
suggests that the Summary scale is well targeted. Reliability is likely to
be reduced by the process of subtesting due to the local dependency
within the subtests, a factor which spuriously inﬂates reliability if not
addressed [43]. The 14-item that make up the Summary scale displayed
excellent reliability of .81when evaluated as individual items (i.e.when
not analysed using subtests).
The present study is limited insofar as the MND-SWS was validated
statistically and has yet to be completed in itsmodiﬁed form by patients
in either research or as part of the clinical assessment process. Such use
would conﬁrm the acceptability of the scale and allow the psychometric
properties of the scale to be tested outside the development sample.
Sample size and budget constraints in the current study precluded the
completion of a secondary analysis using a validation sample. Further
work is planned to administer the MND-SWS to a large sample of
patients with MND, which will allow for validation of the new scale.
The age and sex of our sample are representative of the U.K. research
populations from other studies [44,45]. Patients were recruited from
MND care centres across the U.K. These centres care for MND patients
at all stages of the disease. Awide spread of disability within the current
sample was indicated by a large range of ALSFRS-R scores.
The MND-SWS has a hierarchical factor structure, and may be used
in a number of ways. We suggest that the 15-item Summary scale is
useful for both clinical and research applications. The total score for
the Summary scale can be calculated by summing together the scoreof the constituent items. Greater detail can be gained from the analysis
of the four individual subscales, which we consider to be primarily
useful for research applications and more in-depth investigations
concerning the nature of social withdrawal.
Our ﬁndings support the use of the modiﬁed 14-item MND Social
Withdrawal Scale with MND patients. The new 14-item Summary
scale and the four subscales displayed good internal construct validity,
excellent unidimensionality and were free from gender or age related
item bias.
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